Search
Searching Content indexed under Food, Drugs, Healthcare, Life Sciences by K&L Gates ordered by Published Date Descending.
Links to Result pages
 
1  
 
Title
Country
Organisation
Author
Date
1
In The Weeds: Momentum Builds In Congress To Lift Federal Restrictions On Marijuana
Forty-six states currently have marijuana legalization laws. Twenty-nine states and the District of Columbia have legalized medical marijuana, while seventeen states have allowed access to certain strains for some medical purposes.
United States
8 Aug 2018
2
Trump Administration Seeks Stakeholder Input On New Direction For CMS Innovation Center
On September 20, 2017, the CMS released an informal RFI seeking stakeholder feedback on the future direction of the Center for Medicare and Medicaid Innovation ("CMMI").
United States
9 Oct 2017
3
FDA Seeks Stakeholder Input On Regulatory Reform Efforts
On September 8, 2017, the Food and Drug Administration ("FDA") became the latest in a line of federal departments and agencies to seek public input on approaches to modify regulations...
United States
19 Sep 2017
4
340B Update: HRSA Delays Final Rule On 340B Pricing And Manufacturer CMPs Yet Again
On August 21, 2017, the HRSA published a Notice of Proposed Rulemaking to further delay the effective date of final rules on drug pricing calculations and civil monetary penalties...
United States
29 Aug 2017
5
Recent 11th Circuit Decision Is A Victory For Health Care Providers Challenging Insurer Reimbursement Decisions And A Reminder Of The Importance Of Carefully-Drafted Assignment Of Benefits Clauses
The existence and scope of assignments of benefits from patients to health care providers continues to be critically important to a provider's ability to challenge an insurer's reimbursement decision...
United States
23 Aug 2017
6
CMS Proposes Substantial Payment Reductions In CY 2018 For Off-Campus Hospital Outpatient Departments Subject To The Site-Neutral Rule
On July 20 and 21, 2017, respectively, the Centers for Medicare & Medicaid Services ("CMS") released a proposed rule addressing changes to the hospital Outpatient Prospective Payment System...
United States
17 Aug 2017
7
340B Update: CMS Proposes To Reduce 340B Drug Reimbursement; Draft Executive Order Could Mean Further Changes To The 340B Program
The Trump administration is considering significant changes relating to the 340B Drug Pricing Program, which allows certain categories of safety net providers to access discounted pricing on covered outpatient drugs from manufacturers.
United States
25 Jul 2017
Links to Result pages
 
1